Domača stranB1SX34 • BVMF
add
Boston Scientific
Prejšnji trg. dan.
534,62 R$
Dnevni razpon
534,62 R$ - 534,62 R$
Letni razpon
267,84 R$ - 534,62 R$
Tržna kapitalizacija
133,44 mrd. USD
Povprečni obseg
91,00
V novicah
BSX
0,60 %
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
(USD) | sep. 2024info | Sprememba L/L |
---|---|---|
Prihodek | 4,21 mrd. | 19,34 % |
Stroški poslovanja | 2,17 mrd. | 20,38 % |
Čisti dohodek | 469,00 mio. | −7,13 % |
Čista dobičkovnost prihodkov | 11,14 | −22,21 % |
Earnings per share | 0,63 | 26,00 % |
EBITDA | 1,02 mrd. | 12,65 % |
Efektivna davčna stopnja | 29,90 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
(USD) | sep. 2024info | Sprememba L/L |
---|---|---|
Denar. in kratkor. naložbe | 2,50 mrd. | 162,82 % |
Skupna sredstva | 38,08 mrd. | 11,85 % |
Skupne obveznosti | 17,12 mrd. | 14,80 % |
Celoten lastniški kapital | 20,96 mrd. | — |
Shares outstanding | 1,47 mrd. | — |
Razmerje P/B | 38,05 | — |
Donosnost sredstev | 4,77 % | — |
Donosnost kapitala | 5,63 % | — |
Denarni tok
Neto sprememba denarnih sredstev
(USD) | sep. 2024info | Sprememba L/L |
---|---|---|
Čisti dohodek | 469,00 mio. | −7,13 % |
Denar iz dejavnosti | 1,00 mrd. | 43,55 % |
Denar iz naložb | −1,43 mrd. | −624,37 % |
Denar iz financiranja | 7,00 mio. | −56,25 % |
Neto sprememba denarnih sredstev | −412,00 mio. | −180,31 % |
Prost denarni tok | 612,38 mio. | 43,29 % |
Vizitka
Boston Scientific Corporation, headquartered in Marlborough, Massachusetts and incorporated in Delaware, is a biomedical/biotechnology engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. Boston Scientific is widely known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. With the full acquisition of Cameron Health in June 2012, the company also became notable for offering a minimally invasive implantable cardioverter-defibrillator which they call the EMBLEM subcutaneous implantable defibrillator. Wikipedia
Generalni direktor
Datum ustanovitve
29. jun. 1979
Sedež organizacije
Spletno mesto
Zaposleni
48.000